FDA Says Boston Scientific Corporation Recalls NexStent Products

WASHINGTON, Aug 14 (Reuters) - Boston Scientific Corp is recalling its NexStent carotid artery products because part of the stent’s delivery system can detach and cause injury, U.S. health officials said on Thursday.

MORE ON THIS TOPIC